BioAtla (BCAB) Cash from Operations (2020 - 2026)
BioAtla's (BCAB) quarterly Cash from Operations came in at 5267000.0 in Q1 2026, up 67.66% year-on-year from 3141414.77 in Q1 2025, and up 33.46% quarter-over-quarter from 7915000.0 in Q4 2025.
BioAtla (BCAB) Cash from Operations (2020 - 2026) Analysis & Trends
BioAtla's Cash from Operations history runs 7 years deep, the most recent figure standing at 5267000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 67.66% year-over-year to 5267000.0 in Q1 2026; TTM through Mar 2026 was 37183000.0, a 35.22% increase from a year earlier, with the FY2025 full-year figure at 48204000.0, up 32.99% from the prior year.
- Cash from Operations advanced to 5267000.0 in Q1 2026 per BCAB's latest filing, from 7915000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 5132000.0 in Q3 2024 and bottomed at 30828000.0 in Q1 2024.
- The 5-year median for Cash from Operations is 19193000.0 (2024), against an average of 18814235.29.
- Across the five-year window, Cash from Operations jumped 81.23% in 2024 and plunged 92.54% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 24347000.0 in 2022, then decreased by 22.9% to 29922000.0 in 2023, then soared by 43.91% to 16783000.0 in 2024, then surged by 52.84% to 7915000.0 in 2025, then jumped by 33.46% to 5267000.0 in 2026.
- Per Business Quant, the three latest BCAB Cash from Operations figures stand at 5267000.0 (Q1 2026), 7915000.0 (Q4 2025), and 9881000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | BioAtla | 5.74 Mn | 5.74 Mn | - | -5.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.27 Mn |
| Mar 31, 2026 | -5.27 Mn |
| Dec 31, 2025 | -7.92 Mn |
| Dec 31, 2025 | -7.92 Mn |
| Sep 30, 2025 | -9.88 Mn |
| Sep 30, 2025 | -9.88 Mn |
| Jun 30, 2025 | -14.12 Mn |
| Jun 30, 2025 | -14.12 Mn |
| Mar 31, 2025 | -16.29 Mn |
| Mar 31, 2025 | -16.29 Mn |
| Dec 31, 2024 | -16.78 Mn |
| Dec 31, 2024 | -16.78 Mn |
| Sep 30, 2024 | -5.13 Mn |
| Sep 30, 2024 | -5.13 Mn |
| Jun 30, 2024 | -19.19 Mn |
| Jun 30, 2024 | -19.19 Mn |
| Mar 31, 2024 | -30.83 Mn |
| Mar 31, 2024 | -30.83 Mn |
| Dec 31, 2023 | -29.92 Mn |
| Dec 31, 2023 | -29.92 Mn |